Semaglutide is about to become more affordable
Generic versions of semaglutide are arriving in Canada in early 2026, containing the exact same active ingredient as Ozempic and Wegovy. Prices are expected to drop significantly.
Estimated pricing by generics available
Based on current brand-name price of $320 per pen. Brand-name prices are also expected to decrease as market competition increases.
Why you can trust generic semaglutide
Generic medications authorized for sale in Canada are held to the same rigorous standards as the original brand. Health Canada requires that every approved generic contain the same active ingredient at the same strength, work the same way in the body, and meet identical safety, quality, and manufacturing standards.
Same active pharmaceutical ingredient as Ozempic and Wegovy
Same dosage form, strength, and route of administration
Identical therapeutic effect and bioequivalence demonstrated
Health Canada authorization required before market entry
Frequently asked questions
What are generic drugs?
Generic medications are authorized copies of brand-name drugs. Health Canada requires that they contain the exact same active pharmaceutical ingredients and produce the same therapeutic effect as the original medication. Lower cost does not mean lower quality.
How do generics impact drug pricing?
Canada has a federal pricing framework in which generic drug prices decrease in stages as more manufacturers enter the market. The more competition, the lower the price.
When will prices start to fall?
The exact timing is still uncertain. Prices are expected to decrease in stages throughout 2026 as more generic manufacturers receive authorization and scale production. Initial availability may be limited depending on demand and manufacturing capacity, so supply could be uneven early on.
Will all Semaglutide-based drugs be impacted?
Not necessarily. Price reductions are tied to patent expiry. Because semaglutide specifically is going off-patent, lower prices apply to semaglutide-based medications. Other GLP-1 receptor agonists on different patents are not expected to see the same changes at this time.
How can Phoenix help me access semaglutide?
Phoenix connects Canadian men with licensed physicians who can assess whether semaglutide is clinically appropriate for them, issue a prescription if indicated, and coordinate ongoing care and dosage management. We will update our pricing automatically as generics become available.
